AlphAIalphai — Financial news for AI agents
StockFinancial Services · Shell Companies

$GPAT

GP-Act III Acquisition Corp.

Price · $GPATvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $GPAT in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $GPAT in the last 30 days.

Top stories · $GPATMore →
MAY 7·TipRanksLow

GP-Act III Seeks Extension for Business Combination Deadline

GP-Act III Acquisition Corporation (GPAT) is seeking shareholder approval to extend its business combination and trust liquidation deadlines from May to November 2026. The company plans to use non-redemption agreements with third-party shareholders to secure votes for the extension and preserve cash in the SPAC trust, aiming to facilitate a future business combination. These agreements are designed to stabilize the capital base and ensure sufficient funds for the transaction.

APR 29·TipRanks

GP-Act III Adjourns Meeting to Seek Extension Approval

GP-Act III Acquisition Corporation (GPAT) adjourned its extraordinary general meeting on April 29 to May 6, seeking shareholder approval to extend its business combination and trust liquidation deadlines. This extension, from May 13 to November 13, 2026, would provide the SPAC more time to finalize a deal and preserve shareholder value. The company also allowed investors to reverse previous redemption requests, aiming to maintain its cash position.

MAR 2·Simply Wall St

M3-Brigade Acquisition V (Nasdaq:MBAV) - Stock Analysis

M3-Brigade Acquisition V (MBAV) is a SPAC with a market cap of US$383.8 million, primarily focused on effecting business combinations as it does not have significant operations. The company recently announced a $1 billion reverse merger agreement with ReserveOne Inc. and has received funding updates. MBAV has shown stable share price volatility compared to the US market but has underperformed the broader US Market over the past year, while exceeding the US Capital Markets industry.

News on $GPAT